Neither increased ATF4 nor GADD34 mRNA expression was observed in any of the patient groups, and no significant differences in ATF4 and GADD34 mRNA expression levels were detected between A-NEC-XBP1s patients and A-NEC-XBP1u patients (Figure S2A and S2B). This evidence concerns the gene ATF4 and necrotizing enterocolitis.